03
Apr
Ethiopia is taking steps to begin producing cancer treatment drugs locally, as part of broader efforts to reduce reliance on imports and strengthen the country’s healthcare system. Currently, Ethiopia imports all medications used in cancer treatment. However, a feasibility study is underway to assess the viability of domestic production. Investors have already entered the Kilinto Pharmaceutical Special Economic Zone to initiate projects aimed at manufacturing cancer drugs locally. The Armauer Hansen Research Institute is expected to play a key role in supporting these initiatives. Assistant Professor Mesay W/Mariam, Deputy Director of the Pharmaceutical Industry Development Sector at the institute, said…